GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vifor Pharma AG (LTS:0RPD) » Definitions » Market Cap

Vifor Pharma AG (LTS:0RPD) Market Cap : CHF10,782 Mil (As of Apr. 27, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Vifor Pharma AG Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Vifor Pharma AG's share price for the quarter that ended in Dec. 2021 was CHF163. Vifor Pharma AG's Shares Outstanding (EOP) for the quarter that ended in Dec. 2021 was 65 Mil. Therefore, Vifor Pharma AG's market cap for the quarter that ended in Dec. 2021 was CHF10,577 Mil.

Vifor Pharma AG's quarterly market cap declined from Dec. 2020 (CHF9,015 Mil) to Jun. 2021 (CHF7,685 Mil) but then increased from Jun. 2021 (CHF7,685 Mil) to Dec. 2021 (CHF10,577 Mil).

Vifor Pharma AG's annual market cap declined from Dec. 2019 (CHF11,648 Mil) to Dec. 2020 (CHF9,015 Mil) but then increased from Dec. 2020 (CHF9,015 Mil) to Dec. 2021 (CHF10,577 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Vifor Pharma AG's Enterprise Value for Today is CHF10,375 Mil.


Vifor Pharma AG Market Cap Historical Data

The historical data trend for Vifor Pharma AG's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vifor Pharma AG Market Cap Chart

Vifor Pharma AG Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 76,129.79 6,938.33 11,648.44 9,014.87 10,577.28

Vifor Pharma AG Semi-Annual Data
Jun12 Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11,648.44 9,265.08 9,014.87 7,685.34 10,577.28

Competitive Comparison of Vifor Pharma AG's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, Vifor Pharma AG's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vifor Pharma AG's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vifor Pharma AG's Market Cap distribution charts can be found below:

* The bar in red indicates where Vifor Pharma AG's Market Cap falls into.



Vifor Pharma AG Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Vifor Pharma AG's Market Cap for the fiscal year that ended in Dec. 2021 is calculated as

Market Cap (A: Dec. 2021 )=Share Price (A: Dec. 2021 )*Shares Outstanding (EOP) (A: Dec. 2021 )
=CHF163*64.8913
=CHF10,577

Vifor Pharma AG's Market Cap for the quarter that ended in Dec. 2021 is calculated as

Market Cap (Q: Dec. 2021 )=Share Price (Q: Dec. 2021 )*Shares Outstanding (EOP) (Q: Dec. 2021 )
=CHF163*64.8913
=CHF10,577

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vifor Pharma AG  (LTS:0RPD) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Vifor Pharma AG Market Cap Related Terms

Thank you for viewing the detailed overview of Vifor Pharma AG's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Vifor Pharma AG (LTS:0RPD) Business Description

Traded in Other Exchanges
N/A
Address
Rechenstrasse 37, Saint Gallen, CHE, 9014
Vifor Pharma AG is a specialty drug manufacturing and licensing company. It researches, develops, and produces its pharmaceutical products and markets and distributes them worldwide. Most of its sales are generated in the USA, with Europe also a strong contributor. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Vifor Pharma AG (LTS:0RPD) Headlines

No Headlines